Diabetes-induced dysfunction of retinal Müller cells

Transactions of the American Ophthalmological Society

Volumn 100, Issue , 2002, Pages 339-352

  Puro, Donald G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE TRANSPORTER; GLUTAMIC ACID; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG TARGETING; EXTRACELLULAR SPACE; HYPERGLYCEMIA; HYPOTHESIS; MUELLER CELL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATCH CLAMP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RETINA NERVE CELL; VISION; ANIMAL; ARTICLE; ELECTROPHYSIOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLIA; LONG EVANS RAT; METABOLISM; PATHOLOGY;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTROPHYSIOLOGY; GLUTAMIC ACID; HYPERGLYCEMIA; NEUROGLIA; OXIDATIVE STRESS; PATCH-CLAMP TECHNIQUES; RATS; RATS, LONG-EVANS;

EID: 0036981941     PISSN: 00659533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Bresnick GH. Diabetic retinopathy viewed as a neurosensory disorder. Arch Ophthalmol 1986;104:989-990.
2. Mizutani M, Gerhardinger C, Lorenzi M. Muller cell changes in human diabetic retinopathy. Diabetes 1998;47:445-449.
3. Lieth E, Gardner TW, Barber AJ, et al. Retinal neurodegeneration: early pathology in diabetes. Clin Exp Ophthalmol 2000;28:3-8.
4. Wolter JR. Diabetic retinopathy. Am J Ophthalmol 1961;51:1123-1141.
5. Bloodworth JMB. Diabetic retinopathy. Diabetes 1962;11:1-22.
6. Frank RN. On the pathogenesis of diabetic retinopathy. Ophthalmology 1984;91:626-634.
7. Alder VA, Su EN, Yu DY, et al. Diabetic retinopathy: early functional changes. Clin Exp Pharmacol Physiol 1997;24:785-788.
8. Terasaki H, Hirose H, Miyake Y. S-cone pathway sensitivity in diabetes measured with threshold versus intensity curves on flashed backgrounds. Invest Ophthalmol Vis Sci 1996;37:680-684.
9. North RV, Farrell U, Banford D, et al. Visual function in young IDDM patients over 8 years of age. A 4-year longitudinal study. Diabetes Care 1997;20:1724-1730.
10. Tregear SJ, Knowles PJ, Ripley LG, et al. Chromatic-contrast threshold impairment in diabetes. Eye 1997;1:537-546.
11. Hyvarinen L, Laurinen P, Rovamo J. Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol (Copenh) 1983;61:94-101.
12. Della Sala S, Bertoni G, Somazzi L, et al. Impaired contrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol 1985;69:136-142.
13. Sokol S, Moskowitz A, Skarf B, et al. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol 1985;103:51-54.
14. Brinchmann-Hansen O, Bangstad HJ, Hultgren S, et al. Psychophysical visual function, retinopathy, and glycemic control in insulin-dependent diabetics with normal visual acuity. Acta Ophthalmol (Copenh) 1993;71:230-237.
15. Simonsen SE. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno Study Group. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Lancet 1982;1:121-124.
16. Brunette JR, Lafond G. Electroretinographic evaluation of diabetic retinopathy. Sensitivity amplitude time response. Can J Ophthalmol 1983;18:285-289.
17. Bresnick GH, Palta M. Oscillatory potential amplitudes. Relation to severity of diabetic retinopathy. Arch Ophthalmol 1987;105:929-933.
18. Coupland SG. A comparison of oscillatory potential and pattern electroretinogram measures in diabetic retinopathy. Doc Ophthalmol 1987;66:207-218.
19. Falsini B, Porciatti V, Scalia G, et al. Steady-state pattern electroretinogram ininsulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol 1989;73:193-200.
20. Caputo S, Di Leo MA, Falsini B, et al. Evidence for early impairment of macular function with pattern ERG in type I diabetic patients. Diabetes Care 1990;13:412-418.
21. Juen S, Kieselbach GF. Electrophysiological changes in juvenile diabetics without retinopathy. Arch Ophthalmol 1990;108:372-375.
22. Prager TC, Garcia CA, Mincher CA, et al. The pattern electroretinogram in diabetes. Am J Ophthalmol 1990;109:279-284.
23. Holopigian K, Seiple W, Lorenzo M, et al. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest Ophthalmol Vis Sci 1992;33:2773-2780.
24. Palmowski AM, Sutter EE, Bearse MA Jr, et al. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci 1997;38:2586-2596.
25. Sakai H, Tani Y, Shirasawa E, et al. Development of electroretinographic alterations in streptozotocin-induced diabetes in rats. Ophthalmic Res 1995;27:57-63.
26. Barber A, Lieth E, Khin S, et al. Neural apoptosis in the retina during experimental and human diabetes: early onset effect of insulin. J Clin Invest 1998;102:783-791.
27. Barber AJ, Nakamura M, Wolpert EB, et al. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem 2001;276:32814-32821.
28. Lieth E, Barber A, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 1998;47:815-820.
29. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. Invest Ophthalmol Vis Sci 2000;41:3561-3568.
30. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 2000;4:1971-80.
31. Li Q, Zemel E, Miller B, et al. Expression of glial fibrillary acidic protein (GFAP) in the diabetic retina. Exp Eye Res 2002;74:615-625.
32. Eddleston M, Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 1993;54:15-36.
33. Puro DG, Müller cells: dynamic components of the retina, In: Toyoda J, Murakami M, Kaneko A, et al, eds. The Retinal Basis of Vision. Amsterdam: Elsevier; 1999:233-248.
34. Sarthy V, Ripps H. The Retinal Müller Cell. New York: Kluwer Academic/Plenum Publishers; 2001.
35. Dreher Z, Robinson SR, Distler C. Müller cells in vascular and avascular retinae: a survey of seven mammals. J Comp Neurol 1992;323:59-80.
36. Newman E, Reichenbach A. The Müller cell: a functional element of the retina. Trends Neurosci 1996;19:307-312.
37. Massey SC. Cell types using glutamate as a neurotransmitter in the vertebrate retina. Prog Retinal Res 1990;9:399-425.
38. Derouiche A, Rauen T. Coincidence of 1-glutamate/1-aspartate transporter (GLAST) and glutamine synthetase (GS) immunoreactions in retinal glia: evidence for coupling of GLAST and GS in transmitter clearance. J Neurosci Res 1995;42:131-143.
39. Rauen T, Taylor R, Kuhlbrodt K, et al. High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance. Cell Tissue Res 1998;291:19-31.
40. Pow D, Crook DK. Direct immunocytochemical evidence for the transfer of glutamine from glial cells to neurons: use of specific antibodies directed against d-stereoisomers of glutamate glutamine. Neuroscience 1996;70:295-302.
41. Vorwerk CK, Naskar R, Schuettauf F, et al. Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death. Invest Ophthalmol Vis Sci 2000;41:3615-3621.
42. Lucas DR, Newhouse JP. The toxic effect of sodium L-glutamate on the inner layers of the retina. Arch Ophthalmol 1957;58:193-201.
43. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994;330:613-622.
44. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vis Res 1997;37:3483-3493.
45. Cunha-Vaz JG, Faria de Abrue JR, Campos AJ, et al. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol 1975;59:649-656.
46. Do Carmo A, Ramos P, Reis A, et al. Breakdown of the inner and outer blood retinal barrier in streptozotocin-induced diabetes. Exp Eye Res 1998;67:569-575.
47. Castillo J, Davalos A, Noya M. Progression of ischaemic stroke and excitotoxic amino acids. Lancet 1997;349:79-83.
48. Vorwerk CK, Lipton SA, Zurakowski D, et al. Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci 1996;37:1618-1624.
49. Distler C, Dreher Z. Glial cells of the monkey retina. II. Müller cells. Vis Res 1996;36:2381-2394.
50. Kowluru RA, Engerman RL, Case GL, et al. Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int 2001;38:385-390.
51. Lieth E, LaNoue KF, Antonetti DA, et al. Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. Exp Eye Res 2000;70:723-730.
52. Ambati J, Chalam KV, Chawla DK, et al. Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 1997;115:1161-1166.
53. Rauen T. Diversity of glutamate transporter expression and function in the mammalian retina. Amino Acids 2000;19:53-62.
54. Trotti D, Rizzini BL, Rossi D, et al. Neuronal and glial glutamate transporters possess an SH-based redox regulatory mechanism. Eur J Neurosci 1997;1236-1243.
55. Trotti D, Danbolt NC, Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci 1998;19:328-334.
56. Kowluru RA, Kern TS, Engerman RL, et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 1996;45:1233-1237.
57. Ellis EA, Grant MB, Murray FT, et al. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 1998;24:111-120.
58. Ellis EA, Guberski DL, Somogyi-Mann M, et al. Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 2000;28:91-101.
59. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
60. Brew H, Attwell D. Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells. Nature 1987;327:707-709.
61. Saranatis M, Attwell D. Glutamate uptake in mammalian retinal glia is voltage- and potassium-dependent. Brain Res 1990;516:322-325.
62. Billups B, Rossi D, Attwell D. Anion conductance behavior of the glutamate uptake carrier in salamander retinal glial cells. J Neurosci 1996;16:6722-6731.
63. Eliasof S, Jahr CE. Retinal glial cell glutamate transporter is coupled to an anionic conductance. Proc Natl Acad Sci U S A 1996;93:4153-4158.
64. Horn R, Marty A. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J Gen Physiol 1988;92:145-159.
65. Rae J, Cooper K, Gates P, et al. Low access resistance perforated patch recordings using amphotericin B. J Neurosci Meth 1991;37:15-26.
66. Bridges RJ, Stanley MS, Anderson MW, et al. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 1991;34:717-725.
67. Sarantis M, Ballerini L, Miller B, et al. Glutamate uptake from the synaptic cleft does not shape the decay of the non-NMDA component of the synaptic current. Neuron 1993;11:541-549.
68. Bazan NG, Gordon WC, Marcheselli VL, et al. Experimental models and their use in studies of diabetic retinal microangiopathy. Therapie 1997;52:447-451.
69. + buffering. Nature 1986;324:466-468.
70. Newman EA. Inward-rectifying potassium channels in retinal glial (Müller) cells. J Neuorsci 1993;13:3333-3345.
71. + channels in human and monkey retinal Müller (glial) cells. J Physiol (Lond) 1997;500:593-604.
72. Barry PH. JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements. J Neurosci Meth 1993;51:107-116.
73. Agardh E, Yeh HH, Herrmann R, et al. g-Aminobutyric acid-mediated inhibition at cholinergic synapses formed by cultured retinal neurons. Brain Res 1985;330:323-328.
74. Kusaka S, Kapousta-Bruneau NV, Puro DG. Plasma-induced changes in the physiology of mammalian retinal glial cells: role of glutamate. Glia 1999;25:205-215.
75. + current of Müller glial cells. Neuron 1993;10:1141-1149.
76. Puro DG, Yuan JP, Sucher NJ. Activation of NMDA receptor-channels in human retinal Müller glial cells inhibits inward-rectifying potassium currents. Vis Neurosci 1996;13:319-326.
77. Goldstein IM, Ostwald P, Roth S. Nitric oxide: a review of its role in retinal function and disease. Vision Res 1996;36:2979-2994.
78. Trotti D, Rossi D, Gjesdal O, et al. Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 1996;271:5976-5979.